Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
40.93
-35.93
-87.78%
Share Warrants & Outstandings
Total Reserve
765.35
1,270.66
-505.31
-39.77%
Shareholder's Funds
770.35
1,311.60
-541.25
-41.27%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-41.56
20.36
-61.92
-304.13%
Other Long Term Liabilities
38.45
4.75
33.70
709.47%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.32
2.21
4.11
185.97%
Total Non-Current Liabilities
3.21
27.32
-24.11
-88.25%
Current Liabilities
Trade Payables
456.30
155.54
300.76
193.37%
Other Current Liabilities
140.17
13.07
127.10
972.46%
Short Term Borrowings
0.00
6.35
-6.35
-100.00%
Short Term Provisions
106.53
24.08
82.45
342.40%
Total Current Liabilities
703.00
199.04
503.96
253.20%
Total Liabilities
1,476.56
1,537.95
-61.39
-3.99%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
162.41
532.33
-369.92
-69.49%
Less: Accumulated Depreciation
133.87
75.21
58.66
77.99%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
28.54
457.12
-428.58
-93.76%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
130.28
-130.28
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
69.80
-69.80
-100.00%
Long Term Loans & Advances
69.97
58.86
11.11
18.88%
Other Non Current Assets
0.00
8.47
-8.47
-100.00%
Total Non-Current Assets
134.21
766.64
-632.43
-82.49%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
548.50
174.00
374.50
215.23%
Sundry Debtors
184.88
289.21
-104.33
-36.07%
Cash and Bank
536.70
240.72
295.98
122.96%
Other Current Assets
16.20
2.99
13.21
441.81%
Short Term Loans and Advances
56.07
64.38
-8.31
-12.91%
Total Current Assets
1,342.35
771.31
571.04
74.04%
Net Current Assets (Including Current Investments)
639.35
572.27
67.08
11.72%
Total Current Assets Excluding Current Investments
1,342.35
771.31
571.04
74.04%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,476.56
1,537.95
-61.39
-3.99%
Contingent Liabilities
98.41
15.38
83.03
539.86%
Total Debt
0.00
6.35
-6.35
-100.00%
Book Value per share (adjusted)
308.14
80.11
228.03
284.65%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 38.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Annual - Fixed Assets
Fixed Assets 28.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,342.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024






